Literature DB >> 34107207

Management and Prevention of HIV Among Transgender Adults.

Asa E Radix1.   

Abstract

Transgender individuals face discrimination, violence, social exclusion, and other social, political, and economic factors that result in increased vulnerability to HIV. Rates of viral suppression and uptake of preexposure prophylaxis are lower among transgender individuals than the general population. HIV clinics can help improve these rates by promoting inclusivity and tailoring care to the specific needs of transgender patients. This article summarizes an International Antiviral Society-USA (IAS-USA) webinar presented by Asa E. Radix, MD, PhD, MPH, on August 18, 2020. This webinar is available on demand at https://www.iasusa.org/courses/on-demand-webinar-2020-radix/.

Entities:  

Year:  2020        PMID： 34107207      PMCID： PMC8224242     

Source DB:  PubMed          Journal:  Top Antivir Med        ISSN： 2161-5853


  28 in total

1.  Antiretroviral therapy adherence among transgender women living with HIV.

Authors:  Jae M Sevelius; Adam Carrico; Mallory O Johnson
Journal:  J Assoc Nurses AIDS Care       Date:  2010-03-29       Impact factor: 1.354

2.  Transgender Population Size in the United States: a Meta-Regression of Population-Based Probability Samples.

Authors:  Esther L Meerwijk; Jae M Sevelius
Journal:  Am J Public Health       Date:  2017-02       Impact factor: 9.308

3.  HIV Infection in U.S. Household Population Aged 18-59: Data From the National Health and Nutrition Examination Survey, 2007-2012.

Authors:  Joseph Woodring; Deanna Kruszon-Moran; Geraldine McQuillan
Journal:  Natl Health Stat Report       Date:  2015-09-24

4.  Baseline Characteristics Explain Differences in Effectiveness of Randomization to Daily Oral TDF/FTC PrEP Between Transgender Women and Cisgender Men Who Have Sex With Men in the iPrEx Trial.

Authors:  Megha L Mehrotra; Daniel Westreich; Vanessa M McMahan; Medellena Maria Glymour; Elvin Geng; Robert M Grant; David V Glidden
Journal:  J Acquir Immune Defic Syndr       Date:  2019-07-01       Impact factor: 3.731

5.  Young Transgender Women's Attitudes Toward HIV Pre-exposure Prophylaxis.

Authors:  Sarah M Wood; Susan Lee; Frances K Barg; Marne Castillo; Nadia Dowshen
Journal:  J Adolesc Health       Date:  2017-01-26       Impact factor: 5.012

6.  Youth Risk Behavior Surveillance - United States, 2017.

Authors:  Laura Kann; Tim McManus; William A Harris; Shari L Shanklin; Katherine H Flint; Barbara Queen; Richard Lowry; David Chyen; Lisa Whittle; Jemekia Thornton; Connie Lim; Denise Bradford; Yoshimi Yamakawa; Michelle Leon; Nancy Brener; Kathleen A Ethier
Journal:  MMWR Surveill Summ       Date:  2018-06-15

7.  Engagement in HIV Care Among New York City Transgender Women of Color: Findings from the Peer-Led, TWEET Intervention, a SPNS Trans Women of Color Initiative.

Authors:  S Hirshfield; J Contreras; R Q Luebe; J A Swartz; R Scheinmann; C J Reback; J B Fletcher; K A Kisler; L M Kuhns; L F Molano
Journal:  AIDS Behav       Date:  2021-07

8.  Correlates of antiretroviral adherence and viral load among transgender women living with HIV.

Authors:  Jae M Sevelius; Parya Saberi; Mallory O Johnson
Journal:  AIDS Care       Date:  2014-03-20

9.  HIV Care Engagement Among Trans Women of Color in San Francisco Bay Area Demonstration Projects: Findings from the Brandy Martell Project and TransAccess.

Authors:  E C Wilson; C Turner; S Arayasirikul; T Woods; J Tryon; K Franza; R Lin
Journal:  AIDS Behav       Date:  2021-07

10.  Transgender women on oral HIV pre-exposure prophylaxis have significantly lower tenofovir and emtricitabine concentrations when also taking oestrogen when compared to cisgender men.

Authors:  Eugenie Shieh; Mark A Marzinke; Edward J Fuchs; Allyson Hamlin; Rahul Bakshi; Wutyi Aung; Jennifer Breakey; Tonia Poteat; Todd Brown; Namandjé N Bumpus; Craig W Hendrix
Journal:  J Int AIDS Soc       Date:  2019-11       Impact factor: 5.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.